•  

PRESCRIBING GUIDELINES

Recommendations from the 2022 CDC Clinical Practice Guideline for clinicians involved in pain management. Utah supplemental recommendations are listed where they apply.

Copyright © 2024 DOPL Toolkit for Controlled Substances | All rights reserved.

Initiating

Determining whether or not to initiate opioids for pain.

CDC Recommendation 1: Determining whether or not to Initiate opioids for pain
CDC Recommendation 2: Nonopioid medications for acute pain

Dosage

Selecting opioids and determining opioid dosages.

CDC Recommendation 3: Selecting type and dosage
CDC Recommendation 4: Opioid naive patients
CDC Recommendation 5: Tapering and changing opioid dosages

Duration

Deciding duration of initial opioid prescription and conducting follow-up.

CDC Recommendation 6: Acute Pain
CDC Recommendation 7: Reevaluating risks and benefits during follow ups

Risk Assessment

Assessing risk and addressing potential harms of opioid use.

CDC Recommendation 8: Risk Assessment and Mitigation
CDC Recommendation 9: Using PDMP/CSD to monitor
CDC Recommendation 10: Toxicology Testing
CDC Recommendation 11: Opioid and benzodiazepines combination
CDC Recommendation 12: Treatment for OUD

Implementing the CDC Guidelines

Training for the Guide
Guidelines at a Glance
Clinical Practice Guideline Partner Toolkit
Utah Addendum Guidelines

Pain Management

Acute or Opioid Naïve
Chronic/Long Term
Pediatric Pain

Navigating Conversations with Patients

Stigma Reducing Language
Motivational Interviewing
Difficult Conversations

Patient Evaluation/Risk Identification

Tools for Assessing Substance Use Risk
Tools for Assessing Pain
Tools for Screening Mental Health Conditions and Suicide Risk
Contract for Controlled Substances and Suicide Risk